We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+1.15%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$822M
AUM Growth
-$9.87M
Cap. Flow
-$15M
Cap. Flow %
-1.82%
Top 10 Hldgs %
37.07%
Holding
185
New
7
Increased
36
Reduced
42
Closed
12

Top Buys

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$7.89M
2
EW icon
Edwards Lifesciences
EW
+$1.56M
3
OSPN icon
OneSpan
OSPN
+$1.16M
4
KEYS icon
Keysight
KEYS
+$733K
5
SNY icon
Sanofi
SNY
+$725K

Top Sells

Rank Stock Value
1
MTB icon
M&T Bank
MTB
+$7.95M
2
BCR
CR Bard Inc.
BCR
+$3.09M
3
XOM icon
ExxonMobil
XOM
+$3.04M
4
EPC icon
Edgewell Personal Care
EPC
+$2.4M
5
ZBH icon
Zimmer Biomet
ZBH
+$1.96M

Sector Composition

Rank Sector Weight
1 Technology 35.18%
2 Financials 23.37%
3 Healthcare 16.54%
4 Communication Services 6.83%
5 Consumer Discretionary 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
1
Cisco
CSCO
$450B
$44.1M 5.36%
1,604,955
+10,097
+0.6% +$290K
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.9T
$38.6M 4.7%
1,455,500
-8,328
-0.6% -$223K
SCHW
3
Charles Schwab
SCHW
$177B
$35M 4.26%
1,071,962
-6,789
-0.6% -$215K
AMGN icon
4
Amgen
AMGN
$203B
$31.9M 3.88%
207,634
-1,639
-0.8% -$263K
JPM icon
5
JPMorgan Chase
JPM
$939B
$31.5M 3.83%
464,286
-3,109
-0.7% -$203K
AMZN icon
6
Amazon
AMZN
$2.5T
$28.2M 3.44%
1,301,260
-24,000
-2% -$502K
BCR
7
DELISTED
CR Bard Inc.
BCR
$25.8M 3.14%
151,340
-18,110
-11% -$3.09M
XLNX
8
DELISTED
Xilinx Inc
XLNX
$24.2M 2.95%
548,665
+11,350
+2% +$511K
TEVA icon
9
Teva Pharmaceuticals
TEVA
$35.9B
$22.7M 2.76%
383,963
-2,450
-0.6% -$151K
USB icon
10
US Bancorp
USB
$99.6B
$22.6M 2.75%
520,942
-2,989
-0.6% -$131K
KLAC icon
11
KLA
KLAC
$275B
$22M 2.68%
3,922,280
-17,990
-0.5% -$105K
IBM icon
12
IBM
IBM
$202B
$21.7M 2.64%
139,304
-96
-0.1% -$15.4K
CTSH icon
13
Cognizant
CTSH
$21.5B
$20.4M 2.48%
333,714
-1,780
-0.5% -$112K
CB icon
14
Chubb
CB
$140B
$19.9M 2.42%
195,396
-6,280
-3% -$676K
CIT
15
DELISTED
CIT Group Inc.
CIT
$18M 2.19%
386,661
+9,105
+2% +$424K
GEN icon
16
Gen Digital
GEN
$15.6B
$16.5M 2%
707,629
-28,699
-4% -$700K
QCOM icon
17
Qualcomm
QCOM
$176B
$16.3M 1.98%
260,180
-1,900
-0.7% -$130K
WFC icon
18
Wells Fargo
WFC
$261B
$14.7M 1.79%
261,952
+141,592
+118% +$7.89M
TCF
19
DELISTED
TCF Financial Corporation
TCF
$14.3M 1.74%
859,454
+23,851
+3% +$383K
MSFT icon
20
Microsoft
MSFT
$2.84T
$13.7M 1.67%
311,275
+270
+0.1% +$12.3K
MDT icon
21
Medtronic
MDT
$107B
$12.4M 1.5%
166,827
-2,530
-1% -$193K
AAPL icon
22
Apple
AAPL
$4.89T
$9M 1.1%
286,888
ESRX
23
DELISTED
Express Scripts Holding Company
ESRX
$8.9M 1.08%
100,100
BRCM
24
DELISTED
BROADCOM CORP CL-A
BRCM
$8.86M 1.08%
172,127
-9,366
-5% -$456K
CRM icon
25
Salesforce
CRM
$134B
$8.27M 1.01%
118,720

Similar funds

Oak Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Oak Associates held 185 positions worth $822M, down 1.2% from $831M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Oak Associates's Q2 2015 filing shows 7 new, 36 increased, 42 reduced and 12 closed positions. Its largest new stake was Edwards Lifesciences: 69,000 shares worth $1.64M. The largest sale was M&T Bank, an estimated $7.95M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • Oak Associates's largest Q2 2015 buy was Edwards Lifesciences: 69,000 shares worth $1.64M.
  • Oak Associates added most to Wells Fargo in Q2 2015, an estimated $7.89M increase.
  • Oak Associates's biggest Q2 2015 reduction was CR Bard Inc., cutting an estimated $3.09M.
  • Oak Associates fully exited M&T Bank in Q2 2015, selling an estimated $7.95M.
  • Oak Associates's ten largest holdings make up 37% of its $822M portfolio in Q2 2015.
  • Oak Associates opened 7 new positions and closed 12 in Q2 2015.
  • Oak Associates's portfolio value fell 1.2% quarter-over-quarter to $822M.

Based on Oak Associates's 13F filing for Q2 2015, filed 11 Aug 2015.